Filing Details

Accession Number:
0001125345-19-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-08 17:41:23
Reporting Period:
2019-02-06
Accepted Time:
2019-02-08 17:41:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397266 K Matthew Fust
9704 Medical Center Drive
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-06 6,924 $20.15 7,424 No 4 M Direct
Common Stock Disposition 2019-02-06 6,924 $29.38 500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-02-06 6,924 $0.00 6,924 $20.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-07-05 2024-06-05 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2018.
  2. The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $29.23 to $29.73. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.